{"data":{"billId":"119-hr-10857","congress":119,"type":"HR","number":"10857","title":"To amend the Federal Food, Drug, and Cosmetic Act and Public Health Service Act to advance the next-generation of clinical development of novel treatments and cures, and for other purposes.","shortTitle":null,"originChamber":"House","introducedDate":"2026-10-22","updateDate":"2026-10-23T08:05:54Z","latestAction":{"actionDate":"2026-10-22","text":"Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned."},"policyArea":null,"sponsors":[{"bioguideId":"A000148","district":4,"firstName":"Jake","fullName":"Rep. Auchincloss, Jake [D-MA-4]","isByRequest":"N","lastName":"Auchincloss","party":"D","state":"MA","url":"https://api.congress.gov/v3/member/A000148?format=json"}],"cosponsorsCount":1,"committeesCount":2,"actionsCount":4,"textVersionsCount":0,"url":"https://civdotiq.org/bill/119-hr-10857"},"meta":{"apiVersion":"v1","timestamp":"2026-10-23T11:13:58.855Z","source":"congress.gov","license":"Public Domain","documentation":"https://civdotiq.org/docs/api"}}